News Conference News AHA 2025 Anticoagulation Alone Is Best in AF Patients a Year or More Out From PCI Todd Neale November 09, 2025
News Conference News ESC 2025 AQUATIC: More Than 6 Months After PCI, Don’t Use Aspirin With OAC Todd Neale September 01, 2025
News Daily News Ischemic vs Bleeding Risks: Do Antiplatelet Guidelines Need Rethinking? Yael L. Maxwell January 23, 2025
News Conference News AHA 2024 ENBALV: Edoxaban Matches Warfarin After Bioprosthetic Valve Surgery Yael L. Maxwell November 17, 2024
News Conference News ESC 2021 MASTER DAPT: One Month's Enough in Patients at High Bleeding Risk Shelley Wood August 28, 2021
News Conference News ACC 2021 Apixaban Curbs Subclinical Thrombosis After TAVI in Patients Without Prior OAC Michael O'Riordan May 17, 2021
News Daily News ACC Issues New Guidance Around Antithrombotic Choices in A-fib, VTE Todd Neale December 22, 2020
News Daily News Bleeds on Anticoagulants for A-Fib Can Unveil Occult Cancers Caitlin E. Cox November 06, 2020
News Daily News Antiplatelets Add Risk in Newly Diagnosed A-fib Patients: GARFIELD-AF Caitlin E. Cox March 02, 2020
News Daily News Switch Anticoagulants for A-fib Patients Needing a Stent? RE-DUAL PCI Insights Shelley Wood December 02, 2019
News Conference News ESC 2019 AFIRE Supports Rivaroxaban Monotherapy in A-fib Patients With Stable CAD Todd Neale September 02, 2019
News Daily News Antiplatelets Protective Post-TAVR in A-fib Patients: PARTNER II Data Caitlin E. Cox August 21, 2019
News Conference News TCT 2018 OAC-ALONE: No Clear Answer for Best Therapy Beyond 1 Year After PCI in A-fib Patients Todd Neale September 24, 2018
News Daily News Un Registro Danés Sugiere que la Aspirina No es Necesaria en Pacientes con FA tras un IM o PCI Caitlin E. Cox June 20, 2013
News Daily News Danish Registry Suggests Aspirin Unnecessary in A-fib Patients After MI or PCI Caitlin E. Cox June 20, 2013
Presentation Oral Anticoagulation (OAC) and Antiplatelets inA-fib Patients After MI and PCI Presenter: M. Lamberts June 12, 2013
News Daily News Los betabloqueadores reducen la mortalidad a largo plazo en pacientes de alto riesgo de STEMI Yael L. Maxwell December 13, 2012
News Daily News Beta-Blockers Reduce Long-term Mortality in High-Risk STEMI Patients Yael L. Maxwell December 13, 2012
Presentation ESC 2012 WOEST: First randomised trial that compares two different regimens with and without aspirin in patients on oral anticoagulant therapy (OAC) undergoing coronary stent placement (PCI) Presenter: Willem Dewilde August 28, 2012
News Conference News ESC 2012 WOEST: Clopidogrel Alone Works Best for PCI Patients on Oral Anticoagulants Yael L. Maxwell August 28, 2012